Xeomeen 200 U inj. sol. (pwdr.) i.m. vial

Pajjiż: Belġju

Lingwa: Ingliż

Sors: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingredjent attiv:

Clostridium botulinum Toxin Type A

Disponibbli minn:

Merz Pharmaceuticals GmbH

Kodiċi ATC:

M03AX01

INN (Isem Internazzjonali):

Clostridium Botulinum Toxin, Type A

Dożaġġ:

200 U

Għamla farmaċewtika:

Powder for solution for injection

Kompożizzjoni:

Clostridium Botulinum Toxin, Type A 200 U

Rotta amministrattiva:

Intramuscular use; Intraglandular use

Żona terapewtika:

Botulinum Toxin

Sommarju tal-prodott:

CTI code: 494631-01 - Pack size: 200 U - Commercialisation status: YES - FMD code: 04046222194208 - CNK code: 3445830 - Delivery mode: Medical prescription; CTI code: 494631-02 - Pack size: 2 x 200 U - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 494631-03 - Pack size: 3 x 200 U - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 494631-04 - Pack size: 4 x 200 U - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 494631-05 - Pack size: 6 x 200 U - Commercialisation status: NO - Delivery mode: Medical prescription

L-istatus ta 'awtorizzazzjoni:

Commercialised: Yes

Data ta 'l-awtorizzazzjoni:

2016-04-12